Related Experiment Video
Updated: Jul 27, 2026
08:34
Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
Published on: November 18, 2018
Recent developments and controversies in Kawasaki disease
J A Guzman-Cottrill1, S T Shulman
1Division of Infectious Diseases, Department of Pediatrics, Northwestern University, Feinberg School of Medicine, Children's Memorial Hospital, Chicago, IL 60614, USA. jguzman@childrensmemorial.org
Minerva Pediatrica
|July 14, 2004
Summary
Kawasaki disease, a leading cause of pediatric heart disease, has an unknown cause. Research explores its etiology, pathogenesis, and novel treatments like TNF-alpha inhibitors, while corticosteroid use remains debated.
Area of Science:
- Pediatrics
- Cardiology
- Immunology
Background:
- Kawasaki disease is the primary cause of acquired pediatric heart disease in developed nations.
- The specific etiologic agent and the nature of the inflammatory trigger (superantigen vs. conventional antigen) remain undetermined.
- Pathogenesis involves various growth factors, proteinases, and cytokines contributing to coronary artery disease.
Purpose of the Study:
- To review recent advancements and ongoing debates in understanding Kawasaki disease.
- To explore the etiology, pathogenesis, diagnostic methods, and therapeutic strategies for Kawasaki disease.
Main Methods:
- Literature review of recent developments and controversies.
- Analysis of identified factors in pathogenesis.
- Evaluation of current and emerging treatment strategies.
- Assessment of diagnostic advancements, including non-invasive methods.
Main Results:
- Several factors implicated in pathogenesis identified, including growth factors, proteinases, and cytokines.
- Novel therapeutic targets identified, such as platelet glycoprotein receptor inhibitors and anti-tumor necrosis factor-alpha monoclonal antibodies.
- Efficacy of corticosteroids remains under investigation through clinical trials.
- Development of non-invasive diagnostic tools as alternatives to coronary catheterization.
Conclusions:
- Understanding the etiology and pathogenesis of Kawasaki disease is crucial for effective management.
- Emerging treatments show promise, but further research is needed, particularly regarding corticosteroids.
- Advancements in non-invasive diagnostics are improving patient evaluation.
Related Concept Videos
02:26NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...